BRAIN INFLAMMATION COLLABORATIVE INC

Balance Sheet
Fiscal Year: 2024
Assets in 2024 (Year End)
$232,063
Cash & Equivalents
53%
Receivables (Non-Related)
27%
Other Assets
15%
Prepaid Expenses
5%
Related-Party Receivables
0%
Inventories
0%
Investments
0%
Property, Plant, & Equipment (net)
0%
Liabilities in 2024 (Year End)
$38,154
Payables & Accruals
>99%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$66,136
$122,621
+85%
Receivables (Non-Related)
$2,250
$63,000
+2700%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$5,490
$10,959
+100%
Investments
-
-
-
Property, Plant, & Equipment (net)
-
-
-
Other Assets
$108,378
$35,483
-67%
Total Assets
$182,254
$232,063
+27%
Liabilities
2023
2024
Change
Payables & Accruals
$68,184
$38,154
-44%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$68,184
$38,154
-44%
Net assets
2023
2024
Change
Restricted Net Assets
-
-
-
Unrestricted Net Assets
$114,070
$193,909
+70%
Net assets
2023
2024
Change
Net assets
+$114,070
+$193,909
+70%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)